CytoDyn CYDY
OTC CYDY
$0.20 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

CytoDyn (CYDY) Revenue (2021 - 2022)

Updated

CytoDyn (CYDY) posted Revenue of $34,000 for fiscal Q4 2022 (quarter ended May 31, 2022).

Analysis

CytoDyn (CYDY) Revenue (2021 - 2022) Analysis & Trends

For FY2022 (ended May 31, 2022), CytoDyn's Revenue came in at $300,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 25.31 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 16.99 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 15.03 Bn
10 CytoDyn 318.33 Mn 276.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2022 34,000.00
Nov 30, 2021 225,000.00
Aug 31, 2021 41,000.00
API Access

CytoDyn Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CYDY&period=max&api_key=YOUR_API_KEY